Bruce Jackson
Stock Analyst at Benchmark
(0.84)
# 3,809
Out of 4,883 analysts
123
Total ratings
24.58%
Success rate
-26.63%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.69 | +295.74% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.16 | +548.15% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.44 | +577.20% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.87 | +752.71% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.90 | +693.10% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $59.03 | +35.52% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $7.31 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $52.48 | +23.86% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.67 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $30 | $4.69 | +539.66% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.68 | +83.82% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.18 | +154.24% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.17 | +130.72% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.68 | +4,344.44% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.60 | +1,566.67% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.37 | +4,533.42% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.01 | +2,276.24% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $2.91 | -65.64% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.73 | +586.25% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.20 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.61 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.79 | +21,008.18% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.69
Upside: +295.74%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.16
Upside: +548.15%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.44
Upside: +577.20%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.87
Upside: +752.71%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.90
Upside: +693.10%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $59.03
Upside: +35.52%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.31
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $52.48
Upside: +23.86%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.67
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.69
Upside: +539.66%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.68
Upside: +83.82%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.18
Upside: +154.24%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.17
Upside: +130.72%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.68
Upside: +4,344.44%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.60
Upside: +1,566.67%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.37
Upside: +4,533.42%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.01
Upside: +2,276.24%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $2.91
Upside: -65.64%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.73
Upside: +586.25%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.20
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $16.61
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.79
Upside: +21,008.18%